SCHEMBL1746356

SCHEMBL1746356

CCCCCCCCCCCCCCCCCCCCCC(=O)NCCc1c[nH]c2ccc(O)cc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 11/20 1.00
FAAH O00519 1/20 0.79
PTGS2 P35354 1/20 0.79
MTNR1A P48039 4/20 0.73
SPR P35270 3/20 0.67
MTNR1B P49286 2/20 0.67
KDM4E B2RXH2 1/20 0.67
ALDH1A1 P00352 1/20 0.67
CYP1A2 P05177 1/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2D6 P10635 1/20 0.67
MAPT P10636 1/20 0.67
IDO1 P14902 1/20 0.67
HPGD P15428 1/20 0.67
BLM P54132 1/20 0.67
NOTUM Q6P988 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1129798 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2MTNR1ASPR
SCHEMBL23630270 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2MTNR1ASPR
SCHEMBL23630280 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2MTNR1ASPR
SCHEMBL3815737 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2MTNR1ASPR
SCHEMBL23630267 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2MTNR1ASPR
SCHEMBL23630266 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2MTNR1ASPR
SCHEMBL23643317 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2MTNR1ASPR
SCHEMBL23630276 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2MTNR1ASPR
SCHEMBL23630268 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2MTNR1ASPR
SCHEMBL1746699 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2MTNR1ASPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021141439-A1 COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE CONTAINING COFFEE SILVER SKIN EXTRACT, FRACTION THEREOF, OR COMPOUND ISOLATED THEREFROM 강릉원주대학교산학협력단 2021-07-15 WO claimed
WO-2021141439-A1 COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE CONTAINING COFFEE SILVER SKIN EXTRACT, FRACTION THEREOF, OR COMPOUND ISOLATED THEREFROM 강릉원주대학교산학협력단 2021-07-15 WO disclosed
WO-2021141439-A1 COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE CONTAINING COFFEE SILVER SKIN EXTRACT, FRACTION THEREOF, OR COMPOUND ISOLATED THEREFROM 강릉원주대학교산학협력단 2021-07-15 WO disclosed
US-10583119-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2020-03-10 US disclosed
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2017-09-21 US disclosed
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2017-09-21 US disclosed
US-9486441-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2016-11-08 US disclosed
US-9486441-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2016-11-08 US disclosed
EP-2467026-B1 HEALTHY COFFEE AND METHODS OF ITS PRODUCTION TCHIBO GMBH (DE) 2013-10-23 EP disclosed
US-8524307-B2 Healthy coffee and methods of its production TCHIBO GMBH (DE) 2013-09-03 US disclosed
US-20130156928-A1 HEALTHY COFFEE AND METHODS OF ITS PRODUCTION TCHIBO GMBH (DE) 2013-06-20 US disclosed
EP-2467026-A1 HEALTHY COFFEE AND METHODS OF ITS PRODUCTION Tchibo GmbH (DE) 2012-06-27 EP disclosed
WO-2011134656-A1 HEALTHY COFFEE AND METHODS OF ITS PRODUCTION TCHIBO GMBH (DE) 2011-11-03 WO disclosed
EP-2382868-A1 Healthy coffee and method of its production Tchibo GmbH (DE) 2011-11-02 EP disclosed
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same SIGNUM BIOSCIENCES, INC. 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same PPP2CA, PPP4C, PPP6C TRPV1 4687/4885FAAH 4119/4885PTGS2 2722/4885
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME PPP2CA, PPP4C, PPP6C TRPV1 4687/4885FAAH 4119/4885PTGS2 2722/4885
US-10583119-B2 Compounds, compositions and methods for making the same PPP2CA, PPP4C, PPP6C TRPV1 4687/4885FAAH 4119/4885PTGS2 2722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.